High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
about
The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsTargeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeuticsAlzheimer's disease and insulin resistance: translating basic science into clinical applicationsA window into the heterogeneity of human cerebrospinal fluid Aβ peptidesCross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseasesCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseAccumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neuronsHuntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomersLarge aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugationAβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's diseaseIdentification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosisEvaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's diseaseBrain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles.Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's diseaseDiagnosis and biomarkers of predementia in Alzheimer's disease.Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes.Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation.Immunoprecipitation of amyloid fibrils by the use of an antibody that recognizes a generic epitope common to amyloid fibrils.Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMRDesign of β-amyloid aggregation inhibitors from a predicted structural motif.The proton-pump inhibitor lansoprazole enhances amyloid beta production.Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational studyRole of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapiesElucidating molecular mass and shape of a neurotoxic Aβ oligomer.Characterization of oligomer formation of amyloid-beta peptide using a split-luciferase complementation assayA highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid.Current peptidomics: applications, purification, identification, quantification, and functional analysisThe Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.Specific amyloid β clearance by a catalytic antibody construct.Beta-amyloid auto-antibodies are reduced in Alzheimer's disease.Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's diseaseCerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method.Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.Effects of peptides derived from terminal modifications of the aβ central hydrophobic core on aβ fibrillization.The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
P2860
Q26781635-249C9DE1-F6FC-4208-B817-66F1D5B1ACE6Q26784569-B5AE008F-D84B-4597-9517-CEC91DF1CFFAQ26822002-A26E0D9A-EBE0-4C5A-BF22-85336F076980Q26996487-90ECBFEA-0A84-4EF4-9AA5-E3CFF33D059FQ27010785-DDCD6F76-BC72-4E85-A769-8944FACC7D20Q27021846-3F6A1908-DB40-4A4E-9305-A1A07B25248FQ27023758-9650EA33-7D14-425D-84CC-0B1282A8456DQ27301082-B5345B53-4011-4F76-B2C0-C86EF5352697Q27318766-6D6E81C2-E9D3-4F8B-AB99-531A9918208BQ28481656-237878DC-25D4-4600-940E-E15202AA9B62Q28732085-AB2B8F51-B98C-4520-9ED0-2BF55F15DD32Q28743838-EE81EF6B-207A-4BBC-8C9E-A945136A7687Q30497751-696FE5C4-835E-4C8F-90F4-E49B18EF9667Q31120924-59F5B217-393F-46E6-A1B7-DC3F97D4920EQ33289360-35D40251-D327-4267-BD52-F58E3CAB9A9FQ33596318-7D639147-CB10-442F-B3E4-B636FC8095CBQ33710961-DA3C1366-BA6B-44EC-89B5-9AFC8FEC75D3Q33777509-9A59B276-3265-4D18-876D-F22E56F3B7E1Q34031193-9BB1B982-7989-4AF9-9620-CEA41C6B2CD7Q34043216-4C7AD50E-AE04-40CD-9B34-9F66B5046021Q34075450-3DD59356-E283-4189-A1C4-1DD59E331459Q34100175-5306EE94-DA27-4BC7-90E6-B96387ADB98EQ34228566-9E732BEC-AB4E-4C36-8C53-28BA4F7CBA51Q34261600-88299325-2233-4F76-BC75-867EA1ACEC45Q34631939-C763E9FE-2A1C-457C-94DA-6E9417EFC0DFQ34923134-791E5F6E-EB9D-4B40-B432-2F06D485BEEAQ34974167-AF7EC88A-BD65-4C2D-B902-4213F6D30340Q35013344-2DFA8FA9-1321-4585-85BB-EFD4F4B58777Q35144769-66E47A4C-111D-4684-8BDF-393A65AF4D60Q35206591-5EC12E2A-62BD-48A4-B43C-4A4302ED3957Q35212347-FEECF2BD-B648-4911-B2B9-506FE6F1F288Q35327219-AE5D148B-FD1B-459A-848D-760362CF7B94Q35451085-F7B45EC7-9403-4A92-A469-9DAF8FD2EA59Q35541293-E05321BB-523E-4221-885A-AB285DD05A32Q35643397-F5EFD64A-2270-4D36-8601-4CCFE43D5C43Q35750755-208056CF-F42B-472E-997D-074AD2D957D4Q35804612-DE22FE40-5D22-4055-ADD7-849B7871F28EQ35823536-A64B467A-4D64-4C0D-A724-C32A9EBB1522Q36012311-A1BFDDE6-0CB6-4FB4-820B-A44F949C6A05Q36113757-27F584C4-9700-4794-AA65-C512FF85D436
P2860
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@en
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@nl
type
label
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@en
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@nl
prefLabel
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@en
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@nl
P2093
P921
P356
P1433
P1476
High-molecular-weight beta-amy ...... l fluid of Alzheimer patients.
@en
P2093
Hiroaki Fukumoto
Hiroya Hidaka
Masaki Kondo
Masanori Nakagawa
Noriko Ishigami
Takahiko Tokuda
Takashi Kasai
P304
P356
10.1096/FJ.09-150359
P407
P50
P577
2010-03-25T00:00:00Z